Analytical quality by design: Development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extracts

&NA; Cannabidiol (CBD) and &Dgr;9‐tetrahydrocannabinol (&Dgr;9‐THC) are considered as the most interesting cannabinoids in Cannabis sativa L. for the clinical practice. Since 2013, the Italian law allows pharmacists to prepare and dispense cannabis extracts to patients under medical prescription, and requires the evaluation of CBD and &Dgr;9‐THC content in cannabis extracts before sale. Cannabis olive oil extracts are prepared from dried female cannabis inflorescences, but a standard protocol is still missing. In this study, a fast RP‐HPLC/UV method has been developed to quantify CBD and &Dgr;9‐THC in cannabis olive oil extracts. The analytical quality by design strategy has been applied to the method development, setting critical resolution and total analysis time as critical method attributes (CMAs), and selecting column temperature, buffer pH and flow rate as critical method parameters. Information from Doehlert Design in response surface methodology combined to Monte‐Carlo simulations led to draw the risk of failure maps and to identify the method operable design region. The method was validated according to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines and then implemented in routine analysis. A control strategy based on system control charts was planned to monitor the developed method performances. Evaluation data were recorded over a period of one year of routine use, and both the CMAs showed values within the specifications in every analysis performed. Hence, a new risk evaluation for the future performances of the method was achieved by using a Bayesian approach based on the routine use data, computing the future distribution of the two CMAs. Finally, a study focusing on the monitoring of CBD and &Dgr;9‐THC concentrations in cannabis olive oil extracts was carried out. The developed method was applied to 459 extracts. The statistical analysis of the obtained results highlighted a wide variability in terms of concentrations among different samples from the same starting typology of cannabis, underlining the compelling need of a standardised procedure to harmonise the preparation of the extracts.

[1]  Maitane Olivares,et al.  Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry , 2014, Analytical and Bioanalytical Chemistry.

[2]  G. T. Pollard,et al.  Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States , 2016, Frontiers in Pharmacology.

[3]  S. Benvenuti,et al.  Development of a new extraction technique and HPLC method for the analysis of non‐psychoactive cannabinoids in fibre‐type Cannabis sativa L. (hemp) , 2017, Journal of pharmaceutical and biomedical analysis.

[4]  S Furlanetto,et al.  Optimization and validation of a CZE method for rufloxacin hydrochloride determination in coated tablets. , 2002, Journal of pharmaceutical and biomedical analysis.

[5]  Giuseppe Cannazza,et al.  A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts. , 2018, Phytochemical analysis : PCA.

[6]  Benjamin Debrus,et al.  Design Spaces for analytical methods , 2013 .

[7]  Claudia Giuliani,et al.  Extraction Method and Analysis of Cannabinoids in Cannabis Olive Oil Preparations , 2017, Planta Medica.

[8]  Wieland Peschel,et al.  ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. , 2015, Talanta.

[9]  R. Gotti,et al.  Multivariate optimization of capillary electrophoresis methods: a critical review. , 2014, Journal of pharmaceutical and biomedical analysis.

[10]  Sandra Furlanetto,et al.  Application of quality by design to the development of analytical separation methods , 2012, Analytical and Bioanalytical Chemistry.

[11]  M. Elsohly,et al.  Phytochemistry of Cannabis sativa L. , 2017, Progress in the chemistry of organic natural products.

[12]  S. Furlanetto,et al.  Quality by design approach in the development of an ultra-high-performance liquid chromatography method for Bexsero meningococcal group B vaccine. , 2018, Talanta.

[13]  Benjamin Debrus,et al.  Software-Assisted Method Development in High Performance Liquid Chromatography , 2018 .

[14]  Benjamin Debrus,et al.  Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  Giuseppe Cannazza,et al.  Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. , 2016, Journal of pharmaceutical and biomedical analysis.

[16]  S. Furlanetto,et al.  Enantioseparation and impurity determination of ambrisentan using cyclodextrin-modified micellar electrokinetic chromatography: Visualizing the design space within quality by design framework. , 2016, Journal of chromatography. A.

[17]  A. Darker,et al.  TOTAL QUALITY CONTROL , 1987 .

[18]  R. Verpoorte,et al.  PKS activities and biosynthesis of cannabinoids and flavonoids in Cannabis sativa L. plants. , 2008, Plant & cell physiology.

[19]  Serge Rudaz,et al.  Implementation of a generic liquid chromatographic method development workflow: Application to the analysis of phytocannabinoids and Cannabis sativa extracts , 2018, Journal of pharmaceutical and biomedical analysis.

[20]  Philippe Hubert,et al.  Quantitative determination of salbutamol sulfate impurities using achiral supercritical fluid chromatography , 2017, Journal of pharmaceutical and biomedical analysis.

[21]  Simona Pichini,et al.  Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry , 2017, Clinical chemistry and laboratory medicine.

[22]  Serena Orlandini,et al.  Risk‐based approach for method development in pharmaceutical quality control context: A critical review , 2018, Journal of pharmaceutical and biomedical analysis.

[23]  S Furlanetto,et al.  A comprehensive strategy in the development of a cyclodextrin-modified microemulsion electrokinetic chromatographic method for the assay of diclofenac and its impurities: Mixture-process variable experiments and quality by design. , 2016, Journal of chromatography. A.

[24]  G. Guy,et al.  A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. , 2006, Medical hypotheses.

[25]  W. Weinmann,et al.  Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. , 2014, Forensic science international.

[26]  Arno Hazekamp,et al.  Cannabis Oil: chemical evaluation of an upcoming cannabis-based medicine , 2013 .

[27]  S. Morimoto,et al.  Phytocannabinoids in Cannabis sativa: Recent Studies on Biosynthetic Enzymes , 2007, Chemistry & biodiversity.

[28]  G. di Perri,et al.  Cannabinoids concentration variability in cannabis olive oil galenic preparations , 2018, The Journal of pharmacy and pharmacology.

[29]  M. Schatman,et al.  Cannabis in Pain Treatment: Clinical and Research Considerations. , 2016, The journal of pain : official journal of the American Pain Society.

[30]  Pierre Lebrun,et al.  Implementation of a generic SFC-MS method for the quality control of potentially counterfeited medicinal cannabis with synthetic cannabinoids. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[31]  R. Gotti,et al.  Chiral capillary zone electrophoresis in enantioseparation and analysis of cinacalcet impurities: Use of Quality by Design principles in method development. , 2018, Journal of chromatography. A.

[32]  Ana Stajić,et al.  Quality by Design in the development of hydrophilic interaction liquid chromatography method with gradient elution for the analysis of olanzapine , 2017, Journal of pharmaceutical and biomedical analysis.

[33]  S Furlanetto,et al.  Mixture-process variable approach to optimize a microemulsion electrokinetic chromatography method for the quality control of a nutraceutical based on coenzyme Q10. , 2012, Talanta.

[34]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[35]  John J. Peterson,et al.  Predictive Distributions for Constructing the ICH Q8 Design Space , 2017 .

[36]  Giuseppe Cannazza,et al.  Pharmaceutical and biomedical analysis of cannabinoids: A critical review , 2018, Journal of pharmaceutical and biomedical analysis.

[37]  Gintaras V. Reklaitis,et al.  Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture , 2017 .

[38]  Hermane T. Avohou,et al.  ‘Quality by Design’ approach for the analysis of impurities in pharmaceutical drug products and drug substances , 2017 .

[39]  R. Carlson,et al.  Design of Experiments, Principles and Applications, L. Eriksson, E. Johansson, N. Kettaneh‐ Wold, C. Wikström and S. Wold, Umetrics AB, Umeå Learnways AB, Stockholm, 2000, ISBN 91‐973730‐0‐1, xii + 329 pp. , 2001 .